Skip to main content
. 2023 Mar 28;25(5):189. doi: 10.3892/ol.2023.13774

Figure 3.

Figure 3.

Study cohort. (A) Overall survival of four subgroups in the 2F group; A group: 15–18 RLNs; B group: 19–22 RLNs; C group: 23–29 RLNs; D group: >29 RLNs. (B) Overall survival of the four subgroups in the 3F group; A group: 17–30 RLNs; B group: 31–37 RLNs; C group: 38–50 RLNs; D group >50 RLNs. RLN, resected lymph node; OS, overall survival; 3F, three-field systematic lymphadenectomy; 2F, two-field systematic lymphadenectomy.